Crossmark

Stabilization of vulnerable carotid plaques with proprotein convertase subtilisin/kexin type 9 inhibitor alirocumab

Crossref DOI link: https://doi.org/10.1007/s00701-019-03825-4

Published Online: 2019-02-07

Published Print: 2019-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ogata, Atsushi https://orcid.org/0000-0002-4478-0251
Oho, Kazuhiko

Matsumoto, Noriaki

Masuoka, Jun

Inoue, Kohei

Koguchi, Motofumi

Yoshioka, Fumitaka

Abe, Tatsuya
License Information

Text and Data Mining valid from 2019-02-07
More Information

Article History

Received: 11 December 2018

Accepted: 23 January 2019

First Online: 7 February 2019

Compliance with ethical standards

:

: The authors declare that they have no conflicts of interest.

: Informed consent was obtained from all patients in this case report.